We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Turning Immune Cells into Tiny Anti-Tumor Drug Factories

News   Dec 05, 2018 | Original story from the University of California San Diego School of Medicine

 
Turning Immune Cells into Tiny Anti-Tumor Drug Factories

UC San Diego School of Medicine researchers developed a method to use B cells to manufacture and secrete microRNA-containing vesicles and showed they can inhibit tumor growth in mice. Credit: UC San Diego Health

 
 
 

RELATED ARTICLES

Portable Ebola Test Brings Quicker Diagnosis to Remote Regions

News

Researchers have created a portable and fast-acting test that can distinguish Ebola infections from other fever-causing infectious diseases such as Lassa fever and malaria in around 30 minutes. Although further testing is required, this could be useful during febrile disease outbreaks.

READ MORE

Maturation Process of Natural Killer Cells Mapped

News

Notch signaling is necessary for the normal development and function of natural killer cells. This could be significant for the natural killer cells’ ability to fight cancer and infections.

READ MORE

Precise Engineering of Graphene Could Benefit Lab-on-a-chip Applications

News

A team of NYU researchers has solved a longstanding puzzle of how to build ultra-sensitive, ultra-small electrochemical sensors with homogenous and predictable properties by discovering how to engineer graphene structure on an atomic level.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE